Providing Quality HIV Care
The Latest
This Week in HIV Research: The Burdens We Bear
June 10, 2021: Trauma, burden, and COVID-19 risk among PLWH; sleep and viral suppression; spirituality/religioisity, depression, and HIV risk; why anal cancer screening isn't enough.
COVID-19 Vaccines and the LGBTQ Community: The Messenger Matters
Fearing discrimination and mistreatment, a significant number of LGBTQ folks are in no rush to get vaccinated, surveys show.
A Plan to End Hepatitis C in Michigan Through Harm Reduction and Compassionate Care
Ranked as 7th in the nation for HCV prevalence, Michigan launches an initiative to expand testing, treatment, and assistance and reduce stigma.
This Week in HIV Research: Welcome to the Real World
May 27, 2021: Recycling tenofovir in a second-line regimen; real-life two-drug regimen failure rates; jump-starting ART at sexual health clinics; viability of wearable devices in sleep assessment.
Long-Acting ART Rollout: 3 Considerations for Clinicians
Four months after the approval of cabotegravir/rilpivirine, medical providers still face some tough questions about who might best benefit and how the medication might be covered.
This Week in HIV Research: A Question of Turnout
May 20, 2021: HIV testing and prevalence trends in the U.S.; groups at higher risk for losing viral suppression; intent vs. reality in making clinic appointments; transitioning from pediatric to adult HIV care.
Sexual Health Literacy for Providers Is Crucial to Ending the HIV Epidemic
New York physicians, physician assistants, and nurses may soon be required to talk about sex, gender identity, STIs, and HIV.
Stable Housing Is Health Care For People Living With HIV
A recent study finds viral suppression rates and CD4+ cell counts were significantly lower among people experiencing homelessness.
This Week in HIV Research: Missing the Message
May 13, 2021: Disparities in U=U awareness; sexual satisfaction trends among PLWH; PrEP use among cis women; HCV epidemiology in trans women.
Oregon Poised to Be Third State to Allow Pharmacist-Prescribed PrEP
Will Oregon’s new bill allowing PrEP without a doctor's prescription improve upon similar laws in California and Colorado?
Pick Your Topic
Featured Collections
HIV Spotlight Center: Caring for the Newly Diagnosed Patient
Information, news, and perspectives aimed at helping the health care workforce provide effective care and services for people who have been recently diagnosed with HIV.
This Week in HIV Research
We scan peer-reviewed journals and summarize recently published HIV-related manuscripts with the potential to affect clinical care and services. To beat HIV, you have to follow the science!
Meet the Experts
Paul E. Sax, M.D.
Dr. Sax is director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital (BWH) in Boston.
David Alain Wohl, M.D.
David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.